Consolidated statement of changes in equity
| Retained earnings | |||||||
|---|---|---|---|---|---|---|---|
| Share capital | Supplementary capital | Other reserve capital | Revaluation reserve | Retained profit | Net profit for the period |
Total | |
| Balance as at 1 January 2021 | 147,419 | 9,110,976 | 2,208,982 | 255,833 | (425,778) | 733,095 | 12,030,527 |
| Total comprehensive income for the period | – | – | – | (851,455) | – | 176,298 | (675,157) |
| Net profit for the period | – | – | – | – | – | 176,298 | 176,298 |
| Other comprehensive income for the period | – | – | – | (851,455) | – | – | (851,455) |
| Distribution of retained earnings | – | – | 731,060 | – | 2,035 | (733,095) | – |
| Distribution of retained earnings intended for capital | – | – | 731,060 | – | 2,035 | (733,095) | – |
| Share issue | 100 | – | – | – | – | – | 100 |
| Management stock options* | – | – | 6,073 | – | – | – | 6,073 |
| Other adjustments | – | – | – | – | 88 | – | 88 |
| Balance as at 1 January 2021 | 147,519 | 9,110,976 | 2,946,115 | (595,622) | (423,655) | 176,298 | 11,361,631 |
| Retained earnings | |||||||
| Share capital | Supplementary capital | Other reserve capital | Revaluation reserve | Retained profit | Net profit for the period |
Total | |
| Balance as at 1 January 2020 | 147,419 | 9,110,976 | 1,572,757 | 125,251 | (411,714) | 614,694 | 11,159,383 |
| Total comprehensive income for the period | – | – | – | 130,582 | – | 733,095 | 863,677 |
| Net profit for the period | – | – | – | – | – | 733,095 | 733,095 |
| Other comprehensive income for the period | – | – | – | 130,582 | – | – | 130,582 |
| Distribution of retained earnings | – | – | 628,696 | – | (14,002) | (614,694) | – |
| Distribution of retained earnings intended for capital | – | – | 628,696 | – | (14,002) | (614,694) | – |
| Management stock options* | – | – | 7,529 | – | – | – | 7,529 |
| Other adjustments | – | – | – | – | (62) | – | (62) |
| Balance as at 1 January 2020 | 147,419 | 9,110,976 | 2,208,982 | 255,833 | (425,778) | 733,095 | 12,030,527 |
* The management stock option programme is described in detail in Note 40.